Total: £ 56.28
2026-04-08 | Pages: 95 | Tables: 98
The global Radioactive Microspheres market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landsc...
2026-04-08 | Pages: 93 | Tables: 99
The global Xenon-133 Gas market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This r...
2026-04-08 | Pages: 121 | Tables: 124
The global Fucoidan Powder market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This...
2026-04-08 | Pages: 112 | Tables: 108
The global Nasal Spray Live Attenuated Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econ...
2026-04-08 | Pages: 111 | Tables: 113
The global IL-6R Inhibitor market was valued at US$ 938 million in 2025 and is anticipated to reach US$ 1403 million by 2032, at a CAGR of 6.0% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic la...
2026-04-08 | Pages: 117 | Tables: 109
The global IL-6R Agonist market was valued at US$ 802 million in 2025 and is anticipated to reach US$ 1559 million by 2032, at a CAGR of 10.1% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lan...
2026-04-08 | Pages: 116 | Tables: 113
The global Pharmaceutical Grade PEG-40 Stearate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global eco...
2026-04-08 | Pages: 125 | Tables: 124
The global Taxol market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report cr...
2026-04-08 | Pages: 94 | Tables: 103
The global Live Herpes Zoster Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic land...
2026-04-08 | Pages: 102 | Tables: 90
The global Poloxamer 188 Excipients market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landsc...
2026-04-08 | Pages: 111 | Tables: 116
The global Pharmaceutical Grade Poloxamers market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic...
2026-04-08 | Pages: 98 | Tables: 100
The global Pet Tumor Suppressor Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lands...
2026-04-08 | Pages: 112 | Tables: 109
The global Beauty Medical Dressings market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landsc...
2026-04-08 | Pages: 114 | Tables: 116
The global Medical Grade Beauty Facial Mask market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economi...
2026-04-08 | Pages: 106 | Tables: 100
The global Pet Cancer Targeted Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landsc...